 Home > Biochemistry News > Biotechnology News > WuXi Giant Nuo CAR-T Cell Therapy Launched or Delayed

WuXi Giant Nuo CAR-T Cell Therapy Launched or Delayed

 Last Update: 2021-09-05
 Source: Internet
 Author: User

Tags

ben fuchs products

health canada drug database

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Article source: Medical Rubik's Cube Info

Author: Sunshine

On August 16, WuXi Giant Nuo issued an announcement stating that its targeting CD19 auto-chimeric antigen receptor (CAR) T cell therapy relma-cel injection was used as the third line of relapsed or refractory B-cell lymphoma The new drug marketing application of the therapy is still under review and approval

According to the official website of the Food and Drug Administration, Ruijilunsai entered the administrative approval stage on August 1

According to the PharmaGo database of Medicine Rubik's Cube, the review timeline of Ruijilunsai was changed on August 16, and the acceptance number (CXSS2000036) entered the review sequence of therapeutic biological products-supplementary information-comprehensive review technology

Timeline of part of the review of Ruijilun Competition (Source: PharmaGo)

WuXi Junuo stated that it will actively communicate with the Drug Evaluation Center of the National Medical Products Administration and other competent government departments and pay close attention to the progress of the approval

Ruijilunzai is a CAR-T cell therapy targeting CD19 developed by Juno, an American cell therapy company

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.